APA (7th ed.) Citation

Vloten, J. P. v., Minott, J. A., McAusland, T. M., Ingrao, J. C., Santry, L. A., McFadden, G., . . . Wootton, S. K. (2021). Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy. Elsevier.

Chicago Style (17th ed.) Citation

Vloten, Jacob P. van, Jessica A. Minott, Thomas M. McAusland, Joelle C. Ingrao, Lisa A. Santry, Grant McFadden, James J. Petrik, Byram W. Bridle, and Sarah K. Wootton. Production and Purification of High-titer OrfV for Preclinical Studies in Vaccinology and Cancer Therapy. Elsevier, 2021.

MLA (8th ed.) Citation

Vloten, Jacob P. van, et al. Production and Purification of High-titer OrfV for Preclinical Studies in Vaccinology and Cancer Therapy. Elsevier, 2021.